In compliance with current regulations, let us know which audience you belong to:
Smarter. Scalable.
Designed around your clinical needs.
Our leading dual-therapy platform in a completely overhauled experience.
eye-light® is Espansione Group’s flagship light-based medical device for ophthalmic care.
Designed to support clinicians in managing ocular surface and retinal conditions, eye-light® integrates clinical evidence, scalable innovation, and proven technologies (LM™ LLLT photobiomodulation and OPE™ IPL) to deliver non-invasive, light-based treatments for both anterior and posterior segment conditions, within a single platform.
Introducing the new modular software architecture.
The new eye-light®’s modular design offers up to nine treatment protocols for anterior and posterior care—expandable anytime without replacing the device.
This approach allows practices to extend clinical applications while maintaining the same platform.
Advanced operational intelligence
to support the treatment workflow:
The current eye-light® platform is dedicated to ophthalmology, delivering non-invasive, light-based therapies across the eye.
It supports anterior segment care — from DED/MGD to tear film stabilization and pre/post-surgical optimization.
For the posterior segment, it uses photobiomodulation to support retinal function, preserve vision, and slow Dry AMD (AREDS 2–3) progression.
One platform. Multiple indications. One clinical vision.
eye-light® is built on Espansione Group’s proprietary light-based technologies, developed and validated for ophthalmic use.
Our patented low-level light therapy technology using multiple wavelengths, each designed to elicit specific cellular responses.
OPE™ IPL, Espansione’s patented, software-controlled IPL technology, delivers safe, calibrated thermal impulses with high safety standards.
OPE™ IPL, used exclusively for selected anterior segment conditions.
eye-light® combines Red, Blue and Yellow LM™ LLLT to deliver photobiomodulation therapy across a wide range of anterior and posterior segment conditions.
LM™ LLLT is used in eye-light® for:
OPE™ IPL is Espansione’s patented, software-controlled IPL technology, delivering calibrated thermal impulses with high safety standards.
Using OPE™ IPL on eye-light® is simple. Gentle, non-invasive pulses target the lower eyelid, boosting circulation and supporting anti-inflammatory activity.
* Available exclusively for the treatment of selected anterior segment conditions.
eye-light® is backed by international scientific literature and ongoing clinical research.
The current eye-light® has evolved into a dedicated ophthalmology solution optimized for ocular surface and retinal care, while earlier versions continue to support dermatology and trichology applications.
eye-light® reflects Espansione Group’s vision of specialized, evidence-based and scalable ophthalmic innovation.
This comprehensive solution provides tailored treatments for various conditions, enhancing eye care and promoting skin and hair health.